Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area

Abstract

Chromosome 4q is one of the most common regions with a high frequency of allelic loss in hepatocellular carcinoma (HCC). To identify the HCC-susceptibility locus on chromosome 4q, we have performed linkage and family-based association analyses on Chinese families with HCC from Taiwan, where hepatitis B is hyperendemic. Using 77 microsatellite markers spanning chromosome 4q on 52 multiplex families, we found suggestive evidence of linkage to 4q22.3–28.1 with a maximum two-point heterogeneity LOD (HLOD) score of 2.55 at marker D4S3240 on chromosome 4q25. Multipoint analyses with microsatellite markers in the region 4q22.3–28.1 resulted in a maximum HLOD score of 3.12 and a maximum nonparametric linkage (NPL) Z score of 1.98 (pointwise P=0.0080; region-wide empirical P=0.021) for D4S3240. The evidence for linkage to D4S3240 was seen mostly in a subset of 28 families lacking affected parents, which showed multipoint HLOD and NPL scores of 3.25 and 2.79 (pointwise P=0.0028; region-wide empirical P=0.008), respectively. Family-based association analyses of the 77 microsatellite markers in 191 families (53 multiplex plus 138 singleton families) using the pedigree disequilibrium test provide further support for observed linkage. Additional genotyping in the 52 multiplex families informative for linkage analyses was performed for 29 single-nucleotide polymorphisms around D4S3240. A common haplotype (at markers rs7442180 and rs221330) positioned ∼873 kb away from D4S3240 was associated with HCC, with P=0.0074.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Abecasis GR, Cherny SS, Cookson WO, Cardon LR . (2002). Nat Genet 30: 97–101.

  • Beasley RP . (1982). Hepatology 2(Suppl): 21–26.

  • Befeler AS, Di Bisceglie AM . (2002). Gastroenterology 122: 1609–1619.

  • Blackwelder WC, Elston RC . (1985). Genet Epidemiol 2: 85–97.

  • Bluteau O, Beaudoin JC, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage P et al (2002). Oncogene 21: 1225–1232.

  • Buendia MA . (2000). Semin Cancer Biol 10: 185–200.

  • Cai RL, Meng W, Lu HY, Lin WY, Jiang F, Shen FM . (2003). World J Gastroenterol 9: 2428–2432.

  • Chen CJ, Chen DS . (2002). Hepatology 36: 1046–1049.

  • Ea CK, Sun L, Inoue J, Chen ZJ . (2004). Proc Natl Acad Sci USA 101: 15318–15323.

  • Kong X, Murphy K, Raj T, He C, White PS, Matise TC . (2004). Am J Hum Genet 75: 1143–1148.

  • Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES . (1996). Am J Hum Genet 58: 1347–1363.

  • Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F et al (2001). Gastroenterology 120: 1763–1773.

  • Liu K, Muse S . (2004). http://www.powermarker.net.

  • Martin ER, Monks SA, Warren LL, Kaplan N . (2000). Am J Hum Genet 67: 146–154.

  • Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS . (1994). Cancer Res 54: 4481–4487.

  • Nyholt DR . (2004). Am J Hum Genet 74: 765–769.

  • O'Connell JR, Weeks DE . (1998). Am J Hum Genet 63: 259–266.

  • Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T et al (2000). Hepatology 31: 1073–1079.

  • Ott J . (1986). Genet Epidemiol 1(Suppl): 251–257.

  • Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WA, Steck PA . (1997). Oncogene 14: 369–373.

  • Piao Z, Park C, Park JH, Kim H . (1998). Int J Cancer 79: 356–360.

  • Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B . (2005). Genet Epidemiol 28: 207–219.

  • Shen FM, Lee MK, Gong HM, Cai XQ, King MC . (1991). Am J Hum Genet 49: 88–93.

  • Thorgeirsson SS, Grisham JW . (2002). Nat Genet 31: 339–346.

  • Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N . (2004). J Natl Cancer Inst 96: 434–442.

  • Wands JR . (2004). N Engl J Med 351: 1567–1570.

  • Wang XL, Uzawa K, Imai FL, Tanzawa H . (1999). Oncogene 18: 823–825.

  • Yeh SH, Chen PJ, Lai MY, Chen DS . (1996). Gastroenterology 110: 184–192.

  • Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT et al (2001). Gastroenterology 121: 699–709.

  • Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ et al (2000). J Natl Cancer Inst 92: 1159–1164.

  • Yu MW, Chen CJ . (1994). Crit Rev Oncol Hematol 17: 71–91.

Download references

Acknowledgements

This work was supported by Grants NSC 92-2320-B-002-031 (to M-W Yu) and NSC 92-3112-B002-007 (to P-J Chen) from the National Science Council and DOH92-TD-1054 (National Research Program for Genomic Medicine) (to M-W Yu) from the Department of Health, Executive Yuan, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M-W Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shih, WL., Yu, MW., Chen, PJ. et al. Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area. Oncogene 25, 3219–3224 (2006). https://doi.org/10.1038/sj.onc.1209345

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209345

Keywords

This article is cited by

Search

Quick links